This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers ...

Electronic lab notebooks (ELNs) were introduced to modernize laboratory work. But new research from Sapio Sciences suggests many scientists now see them as obstacles rather than enablers of discovery.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers ...

Discover how the right excipient can support efficient processing, reliable dosing, fast dissolution and a more patient-friendly experience, and learn what galenIQ™ brings to modern sachet development ...

The biopharmaceutical industry currently finds itself at a precarious intersection of unprecedented innovation and antiquated validation. We have unlocked unprecedented capabilities in gene editing ...

Artificial intelligence-enabled self-driving laboratories in bioprocess engineering are most likely to develop as hybrid systems that integrate automated decision-making with sustained human oversight ...

Debates around tariffs and wider trade tensions often center on supply chains and manufacturing, but beneath that conversation lies another, quieter shift – how these forces are reshaping the ...

Welcome to our annual showcase of top technology launches this year for drug development and manufacturing! Every year, The Medicine Maker asks readers to submit their nominations for inspiring ...

Kindeva has officially opened its new UK headquarters and manufacturing site in Loughborough. The 150,000-square-foot facility is designed to focus on metered-dose inhalers (MDIs), including the ...

Drug development is notoriously expensive, time-consuming, and prone to failure. As therapies become more targeted and complex, the need for smarter, more predictive strategies has never been greater.

Moderna has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for ...

The FDA has unveiled its top science and research priorities for FY 2026 under the GDUFA program, including nitrosamine risk, complex drug development, bioequivalence innovations, and the use of AI ...